Centene (CNC) traded down -1.5 % during a 24 hours period ending at 07:01 PM Central Europe on Monday 26th. One Centene stock can currently be bought for about USD 68 on popular exchanges. Current supply of Centene stocks is 493.9 mn. Centene has a current market capitalization of USD 34.7 bn and approximately USD 302.7 mn worth of Centene was traded on exchanges in the last 24 hours. Since last month end, Centene has traded 13.32 % up. Simple moving average of last 200 days is at USD 54.81. The highest price of past 52 weeks was recorded at USD 72.5 on 10/22/2026. 52 weeks low was at USD 31.63 on 03/30/2026.

Summary of the latest news for Centene

Centene Corp. has experienced a series of events affecting its market valuation and cost structure. Recent adjustments in Medicare Advantage star ratings have influenced investor sentiment, with a noted decline following a downgrade in one key California contract. Analysts highlight that the company’s cost base, particularly hospital and nursing‑home utilization in its largest markets, may be higher than peers, potentially impacting margins. While Centene offers generous benefit and premium‑reduction plans, these benefits are not fully reflected in current earnings. Market consensus remains cautiously negative, with a modest 12‑month target reflecting concerns about cost pressures and regulatory adjustments. The company’s financial outlook is therefore viewed as challenging, pending further data on claims reserves and upcoming Medicare Advantage enrollment figures.

Here is how related stocks have performed in the past 24 hours:

  • Coherent (COHR) traded up 0.71 % and now trades at USD 224.98. Current market capitalisation for Coherent is USD 41.2 bn. Coherent has a current price to earnings ratio of 57.76. Coherent Corp. remains a notable player in the technology sector, with recent trading activity reflecting modest gains. The company’s stock closed higher on the most recent trading day, supported by positive analyst sentiment surrounding its product developments. Coherent’s market performance aligns with broader industry trends, where technology firms have experienced steady appreciation. Investors are observing the company’s earnings outlook as part of the broader earnings season, noting that Coherent’s guidance suggests continued growth momentum. The stock’s movement has been influenced by sector dynamics and investor expectations for AI‑related technologies, a theme that has been highlighted across market commentary. Overall, Coherent Corp. shows resilience amid market fluctuations, maintaining a trajectory consistent with its strategic focus on laser and photonics solutions.

  • Ares Management (ARES) traded down -1.31 % and now trades at USD 122.12. Ares Management has a market capitalisation of USD 40.3 bn. Current price/earnings ratio for Ares Management is 56.61.

  • Comfort Usa (FIX) traded down -9.26 % and now trades at USD 1,262.34. Current market capitalisation for Comfort Usa is USD 40.6 bn. Comfort Usa has a current price to earnings ratio of 28.73.

  • Dr Horton (DHI) traded down -0.12 % and now trades at USD 146.35. Current market capitalisation for Dr Horton is USD 41.3 bn. Dr Horton has a current price to earnings ratio of 13.98. U.S. homebuilder D.R. Horton has attracted attention as investors shift focus away from the technology sector amid concerns about an artificial‑intelligence bubble. In recent trading, the company’s shares moved higher, mirroring gains in other homebuilders that have benefited from declining Treasury yields and easing borrowing costs. Analysts note that lower mortgage rates could improve affordability for buyers, potentially easing pressure on builders to subsidize financing and allowing them to retain higher margins on each sale. Horton’s broad geographic presence and mortgage‑financing capabilities are cited as strengths that may support a recovery in demand. The company’s latest quarterly performance showed modest growth in home closings, but cancellations remained a challenge. Market participants are watching upcoming earnings for signals on whether the sector’s rebound will sustain and how the company’s incentive programs and pricing strategies evolve.

  • Illumina (ILMN) traded up 0.01 % and now trades at USD 271.04. Current market capitalisation for Illumina is USD 40.7 bn.

About Centene

Centene Corporation offers multi-line healthcare solutions to individuals across all states and internationally. Their specialty services include medicaid and medicare health plans, treatment compliance, and nurse triage.